The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (Ethyol®)

This publication has 53 references indexed in Scilit:

• Cardioprotection of rat heart myocytes with amifostine (Ethyol®) and its free thiol, WR-1065, in vitro
  European Journal Of Cancer, 1996
• Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action
  Carcinogenesis: Integrative Cancer Research, 1995
• Effects of the modulating agent WR2721 on myelotoxicity and antitumour activity in carboplatin-treated mice
  European Journal Of Cancer, 1994
• Protection against radiation-induced mutagenesis at the hprt locus by spermine and N, N″-(dithiodi-2, 1-ethanediyl)bis-1,3-propanediamine (WR-33278)
  Mutagenesis, 1994
• The radioprotector WR-2721 reduces neutron-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in mouse splenocytes when administered prior to or following irradiation
  Carcinogenesis: Integrative Cancer Research, 1992
• High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1987
• Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide
  New England Journal of Medicine, 1986
• The radioprotector WR1065 reduces radiation-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in V79 cells
  Carcinogenesis: Integrative Cancer Research, 1985
• Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor Response
  Science, 1977
• Localized Areas of High Alkaline Phosphatase Activity in Endothelium of Arteries
  Nature, 1962